Logo image of CLBT

CELLEBRITE DI LTD (CLBT) Stock Fundamental Analysis

USA - NASDAQ:CLBT - IL0011794802 - Common Stock

17.06 USD
-0.11 (-0.64%)
Last: 10/31/2025, 8:00:01 PM
17.51 USD
+0.45 (+2.64%)
After Hours: 10/31/2025, 8:00:01 PM
Fundamental Rating

5

Overall CLBT gets a fundamental rating of 5 out of 10. We evaluated CLBT against 285 industry peers in the Software industry. While CLBT has a great health rating, its profitability is only average at the moment. While showing a medium growth rate, CLBT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CLBT was profitable.
In the past year CLBT had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CLBT reported negative net income in multiple years.
Each year in the past 5 years CLBT had a positive operating cash flow.
CLBT Yearly Net Income VS EBIT VS OCF VS FCFCLBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

CLBT's Return On Assets of -19.17% is on the low side compared to the rest of the industry. CLBT is outperformed by 70.88% of its industry peers.
Looking at the Return On Equity, with a value of -36.96%, CLBT is doing worse than 64.21% of the companies in the same industry.
CLBT has a better Return On Invested Capital (10.23%) than 86.32% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLBT is below the industry average of 11.84%.
The 3 year average ROIC (7.06%) for CLBT is below the current ROIC(10.23%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -19.17%
ROE -36.96%
ROIC 10.23%
ROA(3y)-9.14%
ROA(5y)-1.85%
ROE(3y)-54.72%
ROE(5y)N/A
ROIC(3y)7.06%
ROIC(5y)7.59%
CLBT Yearly ROA, ROE, ROICCLBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

CLBT has a better Operating Margin (14.16%) than 80.35% of its industry peers.
In the last couple of years the Operating Margin of CLBT has grown nicely.
With an excellent Gross Margin value of 84.38%, CLBT belongs to the best of the industry, outperforming 91.93% of the companies in the same industry.
In the last couple of years the Gross Margin of CLBT has remained more or less at the same level.
Industry RankSector Rank
OM 14.16%
PM (TTM) N/A
GM 84.38%
OM growth 3Y10.9%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.66%
GM growth 5Y1.3%
CLBT Yearly Profit, Operating, Gross MarginsCLBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CLBT is creating some value.
CLBT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CLBT has been increased compared to 5 years ago.
CLBT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CLBT Yearly Shares OutstandingCLBT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CLBT Yearly Total Debt VS Total AssetsCLBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 7.68 indicates that CLBT is not in any danger for bankruptcy at the moment.
CLBT has a better Altman-Z score (7.68) than 78.60% of its industry peers.
There is no outstanding debt for CLBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.68
ROIC/WACC1.11
WACC9.21%
CLBT Yearly LT Debt VS Equity VS FCFCLBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

CLBT has a Current Ratio of 1.96. This is a normal value and indicates that CLBT is financially healthy and should not expect problems in meeting its short term obligations.
CLBT has a Current ratio (1.96) which is comparable to the rest of the industry.
CLBT has a Quick Ratio of 1.92. This is a normal value and indicates that CLBT is financially healthy and should not expect problems in meeting its short term obligations.
CLBT has a Quick ratio (1.92) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.92
CLBT Yearly Current Assets VS Current LiabilitesCLBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

CLBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.75%, which is quite good.
The Revenue has grown by 20.48% in the past year. This is a very strong growth!
CLBT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.47% yearly.
EPS 1Y (TTM)16.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)20.48%
Revenue growth 3Y17.68%
Revenue growth 5Y18.47%
Sales Q2Q%18.35%

3.2 Future

Based on estimates for the next years, CLBT will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.94% on average per year.
CLBT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.18% yearly.
EPS Next Y18.9%
EPS Next 2Y12.72%
EPS Next 3Y12.96%
EPS Next 5Y12.94%
Revenue Next Year17.63%
Revenue Next 2Y17.21%
Revenue Next 3Y17.04%
Revenue Next 5Y15.18%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CLBT Yearly Revenue VS EstimatesCLBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
CLBT Yearly EPS VS EstimatesCLBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 37.09, the valuation of CLBT can be described as expensive.
Based on the Price/Earnings ratio, CLBT is valued a bit cheaper than the industry average as 60.70% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.10. CLBT is valued slightly more expensive when compared to this.
CLBT is valuated quite expensively with a Price/Forward Earnings ratio of 31.97.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CLBT is on the same level as its industry peers.
CLBT is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.52, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 37.09
Fwd PE 31.97
CLBT Price Earnings VS Forward Price EarningsCLBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLBT indicates a somewhat cheap valuation: CLBT is cheaper than 64.56% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CLBT is valued a bit cheaper than the industry average as 72.98% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 27.99
EV/EBITDA 47.39
CLBT Per share dataCLBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CLBT's earnings are expected to grow with 12.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.96
PEG (5Y)N/A
EPS Next 2Y12.72%
EPS Next 3Y12.96%

0

5. Dividend

5.1 Amount

No dividends for CLBT!.
Industry RankSector Rank
Dividend Yield N/A

CELLEBRITE DI LTD

NASDAQ:CLBT (10/31/2025, 8:00:01 PM)

After market: 17.51 +0.45 (+2.64%)

17.06

-0.11 (-0.64%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-12 2025-11-12/bmo
Inst Owners44.23%
Inst Owner Change-0.22%
Ins Owners2.65%
Ins Owner ChangeN/A
Market Cap4.17B
Revenue(TTM)436.73M
Net Income(TTM)-150948000
Analysts84.29
Price Target24.14 (41.5%)
Short Float %5.83%
Short Ratio4.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.37%
Min EPS beat(2)12.81%
Max EPS beat(2)15.93%
EPS beat(4)4
Avg EPS beat(4)21.79%
Min EPS beat(4)0.93%
Max EPS beat(4)57.51%
EPS beat(8)8
Avg EPS beat(8)51.82%
EPS beat(12)11
Avg EPS beat(12)53.22%
EPS beat(16)13
Avg EPS beat(16)50.32%
Revenue beat(2)0
Avg Revenue beat(2)-2.3%
Min Revenue beat(2)-3.58%
Max Revenue beat(2)-1.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.52%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)2.78%
Revenue beat(8)5
Avg Revenue beat(8)0.93%
Revenue beat(12)7
Avg Revenue beat(12)0.54%
Revenue beat(16)9
Avg Revenue beat(16)0.41%
PT rev (1m)2.9%
PT rev (3m)-5.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.51%
EPS NY rev (1m)0%
EPS NY rev (3m)6.69%
Revenue NQ rev (1m)-0.31%
Revenue NQ rev (3m)-1.88%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-1.09%
Valuation
Industry RankSector Rank
PE 37.09
Fwd PE 31.97
P/S 9.55
P/FCF 27.99
P/OCF 25.89
P/B 10.21
P/tB 11.29
EV/EBITDA 47.39
EPS(TTM)0.46
EY2.7%
EPS(NY)0.53
Fwd EY3.13%
FCF(TTM)0.61
FCFY3.57%
OCF(TTM)0.66
OCFY3.86%
SpS1.79
BVpS1.67
TBVpS1.51
PEG (NY)1.96
PEG (5Y)N/A
Graham Number4.16
Profitability
Industry RankSector Rank
ROA -19.17%
ROE -36.96%
ROCE 12.96%
ROIC 10.23%
ROICexc 926.92%
ROICexgc N/A
OM 14.16%
PM (TTM) N/A
GM 84.38%
FCFM 34.12%
ROA(3y)-9.14%
ROA(5y)-1.85%
ROE(3y)-54.72%
ROE(5y)N/A
ROIC(3y)7.06%
ROIC(5y)7.59%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.94%
ROCE(5y)9.6%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y10.9%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.66%
GM growth 5Y1.3%
F-Score5
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 114.28%
Cap/Sales 2.77%
Interest Coverage 250
Cash Conversion 222.39%
Profit Quality N/A
Current Ratio 1.96
Quick Ratio 1.92
Altman-Z 7.68
F-Score5
WACC9.21%
ROIC/WACC1.11
Cap/Depr(3y)92.67%
Cap/Depr(5y)99.76%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
EPS Next Y18.9%
EPS Next 2Y12.72%
EPS Next 3Y12.96%
EPS Next 5Y12.94%
Revenue 1Y (TTM)20.48%
Revenue growth 3Y17.68%
Revenue growth 5Y18.47%
Sales Q2Q%18.35%
Revenue Next Year17.63%
Revenue Next 2Y17.21%
Revenue Next 3Y17.04%
Revenue Next 5Y15.18%
EBIT growth 1Y23.19%
EBIT growth 3Y30.51%
EBIT growth 5YN/A
EBIT Next Year32.85%
EBIT Next 3Y23.1%
EBIT Next 5Y19.13%
FCF growth 1Y160.75%
FCF growth 3Y63.25%
FCF growth 5Y65.07%
OCF growth 1Y150.74%
OCF growth 3Y54.2%
OCF growth 5Y52.3%

CELLEBRITE DI LTD / CLBT FAQ

What is the fundamental rating for CLBT stock?

ChartMill assigns a fundamental rating of 5 / 10 to CLBT.


Can you provide the valuation status for CELLEBRITE DI LTD?

ChartMill assigns a valuation rating of 3 / 10 to CELLEBRITE DI LTD (CLBT). This can be considered as Overvalued.


What is the profitability of CLBT stock?

CELLEBRITE DI LTD (CLBT) has a profitability rating of 5 / 10.


What are the PE and PB ratios of CELLEBRITE DI LTD (CLBT) stock?

The Price/Earnings (PE) ratio for CELLEBRITE DI LTD (CLBT) is 37.09 and the Price/Book (PB) ratio is 10.21.


Can you provide the financial health for CLBT stock?

The financial health rating of CELLEBRITE DI LTD (CLBT) is 7 / 10.